Stay updated with breaking news from Clinical Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
17.03.2022 - Enrollment of first 20 patients of the Company’s Phase 2 acute myeloid leukemia (AML) trial completed in Q4 2021 Topline readout of Group 2 active disease anticipated in Q2 2022 Company plans to file INDs in lymphoma and pancreatic cancer by year ...
Hastings Prince Edward Board of Health has appointed a new Medical Officer of Health. Dr. Ethan Toumishey come...
Breaking news headlines about Gilead Sciences linking to 1,000s of websites from around the world
Health officials in Chatham-Kent say they’re facing significant demands on hospital services, due to alarming COVID-19 case counts.